HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marco L Ferrone Selected Research

Radiotherapy

1/2023Complete tumor necrosis after neoadjuvant chemotherapy defines good responders in patients with Ewing sarcoma.
1/2019Complications and reoperations after surgery for 647 patients with spine metastatic disease.
1/2019Assessment and Management of Patients With Metastatic Spinal Cord Compression: A Multidisciplinary Review.
9/2018Assessing the utility of the spinal instability neoplastic score (SINS) to predict fracture after conventional radiation therapy (RT) for spinal metastases.
1/2018Assessing the utility of a prognostication model to predict 1-year mortality in patients undergoing radiation therapy for spinal metastases.
12/2016Are perioperative allogeneic blood transfusions associated with 90-days infection after operative treatment for bone metastases?
7/2015Are Allogeneic Blood Transfusions Associated With Decreased Survival After Surgery for Long-bone Metastatic Fractures?
5/2013Predictors for major wound complications following preoperative radiotherapy and surgery for soft-tissue sarcoma of the extremities and trunk: importance of tumor proximity to skin surface.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Marco L Ferrone Research Topics

Disease

17Neoplasm Metastasis (Metastasis)
01/2023 - 07/2015
13Neoplasms (Cancer)
01/2023 - 05/2013
3Sarcoma (Soft Tissue Sarcoma)
02/2018 - 04/2012
3Infections
06/2017 - 07/2016
2Ewing Sarcoma (Sarcoma, Ewing)
01/2023 - 12/2020
2Bone Diseases (Bone Disease)
01/2022 - 11/2020
2Renal Cell Carcinoma (Grawitz Tumor)
11/2020 - 08/2016
2Wounds and Injuries (Trauma)
01/2019 - 05/2013
1Necrosis
01/2023
1Margins of Excision
01/2023
1Malnutrition (Nutritional Deficiencies)
01/2022
1Inflammation (Inflammations)
01/2022
1Epidural Abscess
08/2020
1Spontaneous Fractures (Pathological Fracture)
01/2019
1Pain (Aches)
01/2019
1Hemorrhage
01/2019
1Giant Cell Tumor of Tendon Sheath
12/2018
1Giant Cell Tumors (Giant Cell Tumor)
01/2018
1Osteosarcoma (Osteogenic Sarcoma)
01/2018
1Chondroblastoma
01/2018
1Bone Cysts (Bone Cyst)
01/2018
1Giant Cell Tumor of Bone
01/2018
1Multiple Myeloma
07/2016
1Bone Fractures (Bone Fracture)
10/2015

Drug/Important Bio-Agent (IBA)

6AlbuminsIBA
01/2022 - 06/2017
5Hemoglobins (Hemoglobin)IBA
01/2020 - 07/2015
2Alkaline PhosphataseIBA
11/2020 - 01/2019
2Biomarkers (Surrogate Marker)IBA
08/2020 - 01/2020
2Serum AlbuminIBA
01/2020 - 01/2019
1Dihydrotachysterol (AT 10)IBA
01/2023
1Tyrosine (L-Tyrosine)FDA Link
11/2020
1Phosphotransferases (Kinase)IBA
11/2020
1TOR Serine-Threonine KinasesIBA
11/2020
1Monoclonal AntibodiesIBA
01/2018
1Histones (Histone)IBA
01/2018
1Hormones (Hormone)IBA
11/2016
1CalciumIBA
01/2016

Therapy/Procedure

8Radiotherapy
01/2023 - 05/2013
7Therapeutics
11/2020 - 04/2012
3Surgical Amputation (Amputations)
12/2020 - 04/2012
3Blood Transfusion (Blood Transfusions)
12/2016 - 07/2015
2Drug Therapy (Chemotherapy)
01/2023 - 11/2016
2Operative Surgical Procedures
07/2021 - 11/2016
2Limb Salvage
12/2020 - 04/2012
1Neoadjuvant Therapy
01/2023
1Aftercare (After-Treatment)
08/2020
1Renal Dialysis (Hemodialysis)
12/2019
1Chemoprevention
01/2019
1Prostheses and Implants (Prosthesis)
06/2017
1Immunotherapy
11/2016
1Metastasectomy
08/2016
1Curettage
08/2016
1Intramedullary Fracture Fixation
07/2016
1Anesthesia
07/2015
1Length of Stay
07/2015